Eton Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Eton Pharmaceuticals will hold its 2025 Annual Meeting of Stockholders virtually on June 10, 2025, to elect a director, ratify the appointment of its accounting firm, and transact other business.
NASDAQ
Eton Pharmaceuticals announces its 2024 Annual Meeting of Stockholders to be held virtually on June 11, 2024, to vote on director elections, executive compensation, auditor ratification, and other business.